REACT expanded-access program in patients with metastatic renal cell carcinoma: real-world data from a European subanalysis

2015 ◽  
Vol 11 (21) ◽  
pp. 2893-2903 ◽  
Author(s):  
Sergio Bracarda ◽  
Sylvie Rottey ◽  
Amit Bahl ◽  
Christian Eichelberg ◽  
Begoña Mellado ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Real World Data ◽  
World Data ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

2018 ◽  
Vol 16 (4) ◽  
pp. e945-e951 ◽  
Author(s):  
Giuseppe Procopio ◽  
Michele Prisciandaro ◽  
Roberto Iacovelli ◽  
Enrico Cortesi ◽  
Giuseppe Fornarini ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Real World Data ◽  
Safety And Efficacy ◽  
World Data ◽  
Access Program

scholarly journals Cabozantinib in metastatic renal cell carcinoma (mRCC): Data from UK expanded access program (EAP)

2018 ◽  
Vol 29 ◽  
pp. viii317
Author(s):  
A. Gomez de Liano Lista ◽  
B. Venugopal ◽  
K. Fife ◽  
S. Symeonides ◽  
N.S. Vasudev ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program
Sign in / Sign up

Export Citation Format

Share Document